Table 1a. Characteristics of patients analyzed in this study.
| Patient | Sex | Age | Survival (months) | Peritumoral infiltration | SAGE | miRNome |
|---|---|---|---|---|---|---|
| Long term | ||||||
| LT1 | M | 34 | 60 | Yes 10% | X | X |
| LT2 | F | 29 | 54 | no | X | X |
| LT3 | F | 71 | 36 | no | X | X |
| LT4 | F | 46 | 53 | Yes 30% | X | |
| Short term | ||||||
| ST2 | F | 62 | 15 | Yes 20% | X | X |
| ST4 | M | 73 | 6 | no | X | X |
| ST5 | F | 70 | 13 | no | X | |
| ST7 | M | 54 | 15 | Yes 30% | X | X |
| ST8 | M | 51 | 30 | Yes 30% | X | X |
| ST9 | M | 64 | 17 | no | X | |
| ST10 | F | 66 | 16 | Yes 5% | X | X |
| ST11 | M | 67 | 13 | no | X | X |
| ST12 | M | 70 | 19 | Yes 30% | X | X |
All patients were diagnosed of primary glioblastoma. The degree of infiltration in the peritumor areas was calculated as in ref. 70. The last two columns indicate which samples underwent SAGE and miRNome analysis, respectively.